Myocardial deformation analysis in late-onset small-for-gestational-age and growth-restricted fetuses using two-dimensional speckle tracking echocardiography: a prospective cohort study
- PMID: 34529908
- DOI: 10.1515/jpm-2021-0162
Myocardial deformation analysis in late-onset small-for-gestational-age and growth-restricted fetuses using two-dimensional speckle tracking echocardiography: a prospective cohort study
Abstract
Objectives: An association between fetal growth restriction (FGR) and increased predisposition to cardiovascular disease (CVD) is suggested. The aim of this study was to evaluate subclinical signs of fetal cardiac remodeling in late-onset small-for-gestational-age (SGA) and growth-restricted fetuses using two-dimensional speckle tracking echocardiography (2D-STE).
Methods: This is a prospective cohort study, including 117 late-onset (≥32 weeks) SGA (birthweight≤10th centile) fetuses and 102 gestational age matched controls. A subgroup analysis was performed: FGR was defined based on either BW (<third centile) or the presence of feto-maternal Doppler abnormalities, the remaining cases were called SGA centile 3-10. 2D-STE based myocardial deformation analyses included longitudinal peak systolic strain (LPSS) and strain rate (LSR) of the global left (LV) or right (RV) ventricle and its individual segments.
Results: Global and segmental LPSS and LSR values showed no significant difference between late-onset SGA and control fetuses for both ventricles (p>0.05). Regarding global and segmental LPSS and LSR values of LV/RV, subgroup analysis revealed no significant difference between the FGR (n=81), SGA centile 3-10 (n=36) and control group.
Conclusions: A mild degree of placental dysfunction seems not to influence myocardial deformation properties measured by 2D-STE.
Keywords: fetal cardiac function; fetal echocardiography; fetal growth restriction; small for gestational age; speckle tracking.
© 2021 Walter de Gruyter GmbH, Berlin/Boston.
References
-
- Crispi, F, Miranda, J, Gratacos, E. Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and opportunities for prevention of adult disease. Am J Obstet Gynecol 2018;218:S869–79. https://doi.org/10.1016/j.ajog.2017.12.012.
-
- Barker, DJ. Fetal origins of cardiovascular disease. Ann Med 1999;31(1 Suppl):3–6. https://doi.org/10.1080/07853890.1999.11904392.
-
- Barker, D. The fetal and infant origins of adult disease. BMJ 1990;301:1111. https://doi.org/10.1136/bmj.301.6761.1111.
-
- Sehgal, A, Skilton, MR, Crispi, F. Human fetal growth restriction: a cardiovascular journey through to adolescence. J Dev Orig Health Dis 2016;7:626–35. https://doi.org/10.1017/s2040174416000337.
-
- Figueras, F, Caradeux, J, Crispi, F, Eixarch, E, Peguero, A, Gratacos, E. Diagnosis and surveillance of late-onset fetal growth restriction. Am J Obstet Gynecol 2018;218:S790–802.e1. https://doi.org/10.1016/j.ajog.2017.12.003.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous